Tirofiban decreases the risk for early neurologic deterioration in patients with noncardioembolic stroke who are seen within 24 hours of symptom onset.
Full results of the ANNEXA-I trial, showing better control of hematoma expansion but an increase in thrombotic events with andexanet vs usual care, are now published in NEJM.
Early mobility in acute ischemic stroke linked to better outcomes at 90 days healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.